Ropes & Gray representedĀ Solarea Bio, a clinical stage biotechnology developing food-derived microbial-based solutions to aid human health, in a first closing of $15 million in a Series B financing led by S2G Ventures with continued participation of Bold Capital Partners, Viking Global Investors, and GG 1978 SICAF SIF. A total of up to $25 million is targeted for this round of financing. The funds will be allocated to the commercial launch of two medical foods designed for the dietary management of bone health and rheumatoid arthritis, respectively. TheĀ financingĀ was announced on May 8.
The Ropes & Gray team was led by venture capital & emerging companies partnerĀ Brad FlintĀ and venture capital & emerging companies associatesĀ Danielle HeinleinĀ andĀ Joe Muller.
